Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles Davis

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transferHua Li, Shih-Wen Lin, Wynetta Giles-Davis, et al.
Gene Therapy|December 2, 2005
Chimpanzee-origin adenovirus vectors as vaccine carriersN Tatsis, L Tesema, E R Robinson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytesHua Li, Samuel L Murphy, Wynetta Giles-Davis, et al.
Nature Protocols|October 30, 2010
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vectorDongming Zhou, Xiangyang Zhou, Ang Bian, et al.
Human Gene Therapy Methods|September 9, 2016
A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene ProductsLarissa H Haut, Amanda L Gill, Raj K Kurupati, et al.
Methods in Molecular Medicine|March 5, 2011
Genetic adjuvantsH C Ertl, S Pasquini, Z He, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vectorScott E Hensley, Ann S Cun, Wynetta Giles-Davis, et al.
Microbes and Infection|December 20, 2022
Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19Mohadeseh Hasanpourghadi, Mikhail Novikov, Robert Ambrose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
A simian replication-defective adenoviral recombinant vaccine to HIV-1 gagJulie C Fitzgerald, Guang-Ping Gao, Arturo Reyes-Sandoval, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2010
Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathwayLauren DiMenna, Brian Latimer, Elizabeth Parzych, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transferHua Li, Shih-Wen Lin, Wynetta Giles-Davis, et al.
Gene Therapy|December 2, 2005
Chimpanzee-origin adenovirus vectors as vaccine carriersN Tatsis, L Tesema, E R Robinson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 25, 2007
Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytesHua Li, Samuel L Murphy, Wynetta Giles-Davis, et al.
Nature Protocols|October 30, 2010
An efficient method of directly cloning chimpanzee adenovirus as a vaccine vectorDongming Zhou, Xiangyang Zhou, Ang Bian, et al.
Human Gene Therapy Methods|September 9, 2016
A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene ProductsLarissa H Haut, Amanda L Gill, Raj K Kurupati, et al.
Methods in Molecular Medicine|March 5, 2011
Genetic adjuvantsH C Ertl, S Pasquini, Z He, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vectorScott E Hensley, Ann S Cun, Wynetta Giles-Davis, et al.
Microbes and Infection|December 20, 2022
Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19Mohadeseh Hasanpourghadi, Mikhail Novikov, Robert Ambrose, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
A simian replication-defective adenoviral recombinant vaccine to HIV-1 gagJulie C Fitzgerald, Guang-Ping Gao, Arturo Reyes-Sandoval, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 23, 2010
Augmentation of primary influenza A virus-specific CD8+ T cell responses in aged mice through blockade of an immunoinhibitory pathwayLauren DiMenna, Brian Latimer, Elizabeth Parzych, et al.
Pageof 4